Insulin resistance and improvements in signal transduction.

Endocrine
Nicolas Musi, Laurie J Goodyear

Abstract

Type 2 diabetes and obesity are common metabolic disorders characterized by resistance to the actions of insulin to stimulate skeletal muscle glucose disposal. Insulin-resistant muscle has defects at several steps of the insulin-signaling pathway, including decreases in insulin-stimulated insulin receptor and insulin receptor substrate-1 tyrosine phosphorylation, and phosphatidylinositol 3-kinase (PI 3-kinase) activation. One approach to increase muscle glucose disposal is to reverse/improve these insulin-signaling defects. Weight loss and thiazolidinediones (TZDs) improve glucose disposal, in part, by increasing insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation and PI 3-kinase activity. In contrast, physical training and metformin improve whole-body glucose disposal but have minimal effects on proximal insulin-signaling steps. A novel approach to reverse insulin resistance involves inhibition of the stress-activated protein kinase Jun N-terminal kinase (JNK) and the protein tyrosine phosphatases (PTPs). A different strategy to increase muscle glucose disposal is by stimulating insulin-independent glucose transport. AMP-activated protein kinase (AMPK) is an enzyme that works as a fuel gauge and becomes acti...Continue Reading

Citations

Jan 5, 2012·Annals of Biomedical Engineering·Jong Hwan Sung, Michael L Shuler
Jul 27, 2007·Cell Biochemistry and Biophysics·William W Winder, David M Thomson
Jun 2, 2010·Nature Reviews. Drug Discovery·Yu-Hua TsengC Ronald Kahn
Mar 30, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·D Osei-HyiamanG Kunos
May 1, 2010·Carcinogenesis·Paolo VineisJohn D Potter
Dec 20, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Didier M Lambert, Giulio G Muccioli
Jun 11, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·André J Scheen, Nicolas Paquot
Sep 27, 2012·American Journal of Therapeutics·Joselyn RojasValmore Bermúdez
Dec 20, 2007·Current Opinion in Nephrology and Hypertension·Jun Wang, Natsuo Ueda
Mar 19, 2008·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Barry BraunBenjamin Goldstein
Jan 15, 2010·American Journal of Physiology. Endocrinology and Metabolism·Carrie G SharoffBarry Braun
Sep 15, 2007·BMC Bioinformatics·Markus KoschorreckErnst Dieter Gilles
Apr 16, 2010·The Journal of Clinical Endocrinology and Metabolism·Resat UnalGouri Ranganathan
Jul 2, 2015·Journal of Burn Care & Research : Official Publication of the American Burn Association·Marc G Jeschke
Aug 28, 2015·Molecular Nutrition & Food Research·Sithandiwe E MazibukoChristo J F Muller
Jun 16, 2009·Neuropharmacology·Changiz TaghibiglouYu Tian Wang
Dec 23, 2008·Journal of Ethnopharmacology·Xiao MaTatsuya Hayashi
Jun 3, 2008·Translational Research : the Journal of Laboratory and Clinical Medicine·Kun-Der LinShyi-Jang Shin
Apr 30, 2008·Metabolism: Clinical and Experimental·Lourdes IbáñezFrancis de Zegher
Apr 16, 2008·The Journal of Pediatrics·Joan C HanJack A Yanovski
Nov 8, 2015·Life Sciences·Amie J Dirks-Naylor
May 25, 2007·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Héctor GiralVíctor Sorribas
Oct 16, 2008·Medicinal Research Reviews·Michael L MohlerDuane D Miller
Mar 13, 2014·Acta Physiologica·A Guadalupe-GrauJ W Helge
Jul 28, 2009·International Journal of Cancer. Journal International Du Cancer·Michelle L AspMartha A Belury
Oct 2, 2015·Aging and Disease·João M N Duarte
May 12, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A GiaccariG Muscogiuri
Apr 10, 2013·Medical Hypotheses·Roberto Sánchez-Jiménez, Noé Alvarado-Vásquez
Feb 20, 2007·Biochimica Et Biophysica Acta·Gary L Johnson, Kazuhiro Nakamura
Jul 16, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·C MoserJ Drewe
Jun 22, 2016·Nature Communications·Jérémie GautheronTom Luedde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.